← FDA Drug Approvals (Drugs@FDA)

BRIUMVI

BLA · Biologics License Application · Sponsor: TG THERAPEUTICS, INC · Approved 2022-12-28

Drug application

FDA Application #

BLA761238

Application type

Biologics License Application

Brand name

BRIUMVI

Generic name

UBLITUXIMAB

Active ingredients

UBLITUXIMAB-XIIY

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

TG THERAPEUTICS, INC

Manufacturer

TG Therapeutics, Inc.

First approval

2022-12-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown